CARGO Therapeutics, Inc. Common Stock

CRGX · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$167,502-$98,147-$40,951-$5,850
Dep. & Amort.$7,074$3,692$1,444$147
Deferred Tax$0$0$1,216$0
Stock-Based Comp.$17,972$3,327$297$507
Change in WC$5,774$2,209$2,967$254
Other Non-Cash-$3,060$7,755$5,955$0
Operating Cash Flow-$139,742-$81,164-$29,072-$4,942
Investing Activities
PP&E Inv.-$4,447-$8,277-$3,282-$442
Net Acquisitions$0$0$0$0
Inv. Purchases-$604,874$0$0$0
Inv. Sales/Matur.$304,969$0$0$0
Other Inv. Act.-$727-$715$0$0
Investing Cash Flow-$305,079-$8,992-$3,282-$442
Financing Activities
Debt Repay.$0$3,498$28,453$0
Stock Issued$102,888$296,607$5,732$5,414
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$581$194,478$5,732$5,414
Financing Cash Flow$103,469$494,583$34,185$5,414
Forex Effect$0$0$0$0
Net Chg. in Cash-$341,352$404,427$1,831$30
Supplemental Information
Beg. Cash$406,299$1,872$41$11
End Cash$64,947$406,299$1,872$41
Free Cash Flow-$144,189-$90,156-$32,354-$5,384